Dr. Sainath Bhethanabhotla
QaliddaLa-taliye sare
Takhsus gaar ahDhakhtarka Oncologist
Khibrad 19 sano oo waayo-aragnimo ah
Luuqadaha lagu hadloEnglish, Hindi, Telugu
Ku saabsan Dr. Sainath Bhethanabhotla
- Dr. Sainath Bhethanabhotla waa lataliye sare iyo madaxa caafimaadka Oncology oo khibrad u leh daryeelka kansarka iyo cudurrada dhiigbaxa.
- Waxa uu waayo-aragnimo ballaadhan u leeyahay kansarka carruurta iyo dadka waaweyn isaga oo diiradda saaraya borotokoolka daaweynta caddaynta ku salaysan.
- Waxa uu ku xidhan yahay cusbitaalada hormuudka ka ah Hyderabad oo ay ku jiraan Cisbitaalada CARE iyo Machadka Sayniska Caafimaadka ee Krishna.
- Waxa uu wax ku darsaday tacliin iyo cilmi baaris oo muhiim ah oo ku saabsan oncology oo lagu daabacay joornaalada caalamiga ah ee sumcadda leh.
Takhafasho & Xaaladaha la daaweeyay
Immunotherapy
Chemotherapy
Daaweynta Shucaaca
Proton Therapy
Daawaynta La Beegsado
Waxbarasho
MBBS,
MD,
DM,
Khibrad shaqo ee Dr. Sainath Bhethanabhotla
Dr. Sainath Bhethanabhotla has worked at MNJ Institute of Oncology and Regional Cancer Centre.
He has served at Krishna Institute of Medical Sciences, Hyderabad.
He is currently working at CARE Hospitals, Hyderabad and Soumya Hospitals, Hyderabad.
He has extensive experience in pediatric oncology and medical oncology practice.
Abaalmarino & Aqoonsi
Wuxuu helay Sorel Catherine Prize ee Postgraduate-ka ugu Fiican ee Caafimaadka Carruurta.
Waxa uu ku hubsaday booska 2nd ee warqadda billadda dahabka ah ee NNF ee 2012.
Wuxuu ku helay deeq waxbarasho oo loogu talagalay bandhigga afka ee SIOP 2015.
Waxaa lagu abaalmariyay Abaalmarinta Guusha Abstract ee Kulanka Bulshada Maraykanka ee Hematology ee 2017.
Xiriirinta daabacashada
Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, iyo al. Daawaynta ka dib PET-CT Halkii ay ahaan lahayd Ku-meel-gaadhka PET-CT Isticmaalka shuruudaha Deauville Waxay saadaalisaa natiijada ka soo baxda Caafimaadka Carruurta ee Hodgkin Lymphoma: Daraasad Mustaqbal ah oo Isbarbardhigga PET-CT iyo Sawirka Caadiga ah. J Nucl Med. 2016 Oktoobar 6; (XILKA SAAMAYNTA – 10.06)
Bhethanabhotla S, Bakhshi S. Jiritaanka arrimaha khatarta ah ma saameeyaan natiijada marxaladda hore ee carruurta ee Hodgkin lymphoma ee lagu daweeyay ABVD. Ann Hematol. 2016 Nof 18; (XILKA SAAMAYNTA – 3.63)
Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S, iyo al. Natiijooyinka horumarsan ee Hodgkin lymphoma ee carruurta lagu daaweeyay ABVD iyo saadaaliyeyaasha badbaadada hoose: daraasad xarun badan oo bukaanno 186 ah. Leuk Lymphoma 2016 Diseembar 6;1–7. (XILKA SAAMAYNTA – 2.99)
Bhethanabhotla S, Bakhshi S. Jawaab: Midna PET-CT daawaynta ka dib ama PET-CT ku meel gaadhka ah iyadoo la isticmaalayo shuruudaha Deauville ma saadaaliyo natiijada ilmaha ee Hodgkin lymphoma. J Nucl Med. 2016 Diseembar 8; (XILKA SAAMAYNTA – 10.06)
Bhethanabhotla S, Tiwari A, Sharma MC, Vishnubhatla S, Bakhshi S. Muhiimadda Saadaasha ee IL-6 ee Hodgkin Lymphoma. Hindi J Pediatr. 2019 Juun 1;86 (6):551–4. (XILKA SAAMAYNTA – 1.96)
Mittal A, Bhethanabhotla S, Ganguly S, Vishnubhatla S, Khadgawat R, Patel C, iyo al. Saamaynta dambe ee badbaadayaasha Hodgkin lymphoma ee carruurta ka dib daawaynta isku midka ah ee ABVD leh ama aan lahayn shucaac. Kansarka Dhiiga ee Ilmaha. 2021 Nof;68(11):e29293. (XILKA SAAMAYNTA – 3.16)
Bhethanabhotla S, Pramanik R, Srivastava P, Mehta P, Patel A, Biswas B, iyo al. Chemotherapy ee Kansarka Midabka inta lagu jiro Faafida COVID-19. Hindi J Med Paediatr Oncol. 2020 Mars;41(2):156–60.
Bhethanabhotla S, Thukral A, Sankar MJ, Agarwal R, Paul VK, Deorari AK. Saamaynta booska dhallaanka inta lagu jiro daaweynta sawir-qaadista ee maareynta hyperbilirubinemia ee xilliga dhalmada ka hor iyo xilliga dhallaanka: tijaabo la kantaroolay oo la kala soocay. J Perinatol. 2013 Oct;33 (10):795–9. (XILKA SAAMAYNTA – 2.52)
Websaydhkeenu wuxuu adeegsadaa cookies. Qaanuunka Arrimaha Khaaska ah.